BioPharmX Corporation (BPMX) reported the earnings of $-0.13/Share in the last quarter where the estimated EPS by analysts was $-0.16/share. The difference between the expected and actual EPS was $0.03/share, which represents an Earnings surprise of 18.8%.
Many analysts are providing their Estimated Earnings analysis for BioPharmX Corporation and for the current quarter 2 analysts have projected that the stock could give an Average Earnings estimate of $-0.1/share. These analysts have also projected a Low Estimate of $-0.12/share and a High Estimate of $-0.08/share.
In case of Revenue Estimates, 2 analysts have provided their consensus Average Revenue Estimates for BioPharmX Corporation as 30 Million. According to these analysts, the Low Revenue Estimate for BioPharmX Corporation is 30 Million and the High Revenue Estimate is 40 Million. The company had Year Ago Sales of 35 Million.
Some buy side analysts are also providing their Analysis on BioPharmX Corporation, where 0 analysts have rated the stock as Strong buy, 3 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. 3 Analysts reported that the Price Target for BioPharmX Corporation might touch $3 high while the Average Price Target and Low price Target is $3 and $3 respectively.
To analyze a stock, one should look for Upgrades and Downgrades of a stock. BioPharmX Corporation got Initiated on 15-Apr-16 where investment firm Maxim Group Initiated the stock to Buy.
BioPharmX Corporation closed its last trading session at $0.54 with the gain of 2.39%. The Market Capitalization of the company stands at 38.33 Million. The Company has 52-week high of $1.5 and 52-week low of $0.19. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 19.93% where SMA50 and SMA200 are 23.4% and 5.67% respectively. The Company Touched its 52-Week High on Mar 28, 2016 and 52-Week Low on Nov 14, 2016.
The Relative Volume of the company is 7.34 and Average Volume (3 months) is 892.16 million. BioPharmX Corporation P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.
The company shows its Return on Assets (ROA) value of -566.1%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is 0%.
While looking at the Stock’s Performance, BioPharmX Corporation currently shows a Weekly Performance of 22.87%, where Monthly Performance is 31.33%, Quarterly performance is 37.2%, 6 Months performance is -26.28% and yearly performance percentage is -59.64%. Year to Date performance value (YTD perf) value is 47.83%. The Stock currently has a Weekly Volatility of 13.03% and Monthly Volatility of 8.39%.